Coherus Oncology, Inc. (CHRS) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 117 institutional investors hold a position in Coherus Oncology, Inc. (NASDAQ:CHRS).

• The collective stake of institutional investors in Coherus Oncology moved to 44.1% in December 2025, a shift down from the 45.1% reported for September 2025.
• In percentage terms, this reflects as a holdings change of 1.87% quarter on quarter, and a decrease of 4.10% year over year.
• A review of institutional activity for Coherus Oncology shows 56 of 117 filers increasing their positions, while 33 reduced their stake, and 28 remained unchanged.
• Collectively, institutional investors increased their stake in Coherus Oncology to 50.57Mn shares as of December 2025, a change that is up by 927.67K shares quarter on quarter and down 15.50Mn shares year over year.
• With 10.56Mn shares, BlackRock, Inc. commands the largest institutional position in Coherus Oncology as of December 31, 2025, equating to 9.22% of the company.
• Among the most significant buyers of Coherus Oncology during December 2025 were NOMURA ASSET MANAGEMENT INTERNATIONAL INC. (900.00K), MILLENNIUM MANAGEMENT LLC (660.45K), GSA CAPITAL PARTNERS LLP (477.48K), TWO SIGMA INVESTMENTS, LP (468.16K), JANE STREET GROUP, LLC (392.03K).
• Leading sellers of Coherus Oncology stock in December 2025 included TANG CAPITAL MANAGEMENT LLC (2.37Mn), ROYAL BANK OF CANADA (330.42K), VANGUARD GROUP INC (292.21K), LPL Financial LLC (210.60K), UBS Group AG (185.14K).
• The top 10 institutional holders of Coherus Oncology for the quarter ending December 2025 included BlackRock, Inc. (10.56Mn), VANGUARD GROUP INC (10.03Mn), Kohlberg Kravis Roberts & Co. L.P. (3.04Mn), GEODE CAPITAL MANAGEMENT, LLC (2.75Mn), TANG CAPITAL MANAGEMENT LLC (2.72Mn), STATE STREET CORP (2.22Mn), CM Management, LLC (2.10Mn), C WorldWide Group Holding A/S (1.93Mn), PANAGORA ASSET MANAGEMENT INC (1.62Mn), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (935.24K).